Aptus Pharma Limited (BOM:544529)

Aptus Pharma Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	31	7.98	1.94	-	0.38
Depreciation & Amortization	2.65	2.15	1.81	-	0.43
Other Amortization	-	-	0	-	-
Provision & Write-off of Bad Debts	-	-	-	-	0.02
Other Operating Activities	3.71	1.95	1.26	-	0.72
Change in Accounts Receivable	-22.86	-9.56	-5.49	-	-3.48
Change in Inventory	-36.32	-11.27	-9.04	-	-3.8
Change in Accounts Payable	-0.45	-0.1	4.54	-	1.25
Change in Other Net Operating Assets	3.9	-12.89	3.17	-	3.75
Operating Cash Flow	-18.38	-21.75	-1.81	-	-0.73
Capital Expenditures	-6.22	-3.3	-3.53	-	-0.77
Other Investing Activities	0.77	0.25	-	-	-0.05
Investing Cash Flow	-5.45	-3.05	-3.53	-	-0.82
Short-Term Debt Issued	63.88	11.44	0.13	-	-
Long-Term Debt Issued	-	19.52	9.4	-	3.17
Total Debt Issued	63.88	30.96	9.53	-	3.17
Long-Term Debt Repaid	-13.39	-	-	-	-1.01
Net Debt Issued (Repaid)	50.49	30.96	9.53	-	2.16
Issuance of Common Stock	21	-	-	-	-
Other Financing Activities	-4.66	-2.39	-1.43	-	-0.76
Financing Cash Flow	66.83	28.57	8.1	-	1.4
Net Cash Flow	43	3.78	2.76	-	-0.15
Free Cash Flow	-24.6	-25.04	-5.34	-	-1.5
Free Cash Flow Margin	-10.02%	-14.02%	-3.84%	-	-2.94%
Free Cash Flow Per Share	-5.06	-16.69	-7.31	-	-2.40
Cash Interest Paid	4.66	2.39	1.43	-	0.76
Cash Income Tax Paid	11.14	3.39	1.18	-	0.29
Levered Free Cash Flow	-32.32	-18.03	-6.72	-	-5.6
Unlevered Free Cash Flow	-30.46	-17.03	-6.11	-	-5.24
Change in Working Capital	-55.74	-33.82	-6.82	-	-2.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.